Följande forskare har tilldelats anslag:

Transkript

1 Bajalica Lagercrantz, Svetlana Predisposition, prediktion och prevention av ärftlig bröstcancer Belkic, Dzevad Further Critical Steps towards Effective Molecular Imaging through Optimized Magnetic Resonance Spectroscopy for Personalized Cancer Medicine Bergquist, Annika Primär skleroserande cholangit en premalign sjukdom Björnstedt, Mikael Redoxenzymer och selenföreningar vid diagnostik och behandling av terapiresistent tumörsjukdom Brandberg, Yvonne Långtidsuppföljning av kvinnor med hög risk ärftlig risk för bröstcancer: onkologiska, kirurgiska och patientrapporterade aspekter Carlson, Joseph Personalized Cancer Medicine in Gynecologic Sarcomas: Diagnosis and Treatment

2 De Petris, Luigi A personalized cancer medicine program to improve lung cancer management: integration of registry data, biomarkers and novel treatment strategies Dobra, Katalin Integrerad strategi för individanpassad och målinriktad behandling genom molekylär kartläggning och klinisk validering av biomarkörer i maligna exsuda Egevad, Lars Genetics, Protein Expression and Clinical Standardization of Prostate Cancer Ekman, Simon Targeted Therapies and Treatment Resistance in Lung Cancer Discovery of Novel Biomarkers and Therapy Falconer, Henrik Near infraredfluorescent teknik för påvisande av portvaktslymfkörtlar vid endometrieoch cervixcancer Farnebo, Marianne RNA guided repair of DNA double strand breaks and its relationship to cancer

3 Foukakis, Theodoros Individualizing treatment in breast cancer design, conduct and analysis of translational clinical trials Fornander, Tommy Randomiserade studier av lokal och systemisk behandling av primär bröstcancer. Professor Grandérs forskargrupp Drug development to overcome anti cancer drug resistance and the Role of noncoding RNA Göndör, Anita Perturbed 3D epigenome organisation: a novel therapeutic target to eliminate cancer stem cell states Haglund, Felix Telomerasaktivitet i chondrosarkom Hansson, Johan Translationella studier av malignt melanom Hartman, Johan Patient derived organotypic cell cultures for therapy prediction

4 Hedenfalk, Ingrid Novel Targeted Treatment Strategies in Ovarian and Endometrial Cancer PARP Inhibition and Immune Checkpoint Blockade Humblas fond Hultcrantz, Rolf Analys av faeces, markörer för adenom och colorectal cancer Höiom, Veronica Studier på ärftliga faktorer med association till melanominsjuknande, överlevnad i melanom och terapirespons Jafari, Rozbeh Predictive resistance and therapeutic biomarkers in childhood leukemia using thermal proteomics Jakobsson, Per Johan Immunomodulating functions of prostaglandin E2 in the tumor microenvironment, a novel target for therapeutic intervention Jönsson, Göran Improved molecular understanding of tumor and immune cell interaction in melanoma tumors Humblas fond

5 Lagergren, Jesper Oesophageal cancer: Tailored surgical treatment Lagergren, Pernilla Towards improved survivorship among oesophageal cancer patients Larsson, Catharina Molecular background of endocrine tumor development telomerase activation and genetic drivers Lennartsson, Andreas Epigenetic regulation and single cell drug response in leukemic stem cells Lewensohn, Rolf Developing novel therapies for precision of lung cancer treatment Lui, Weng Onn Merkel cell carcinoma biobanking and research: Improving biology and treatment outcomes

6 Maddalo, Gianluca Patient stratification strategies for therapies used in clinics and in clinical trials Massoumi, Ramin Ny behandling för patienter med hudcancer Humblas fond Nilsson, Magnus Två randomiserade studier vid kurativt syftande behandling av matstrups och övre magmunscancer i ett nordiskt multicenternätverk Nilsson, Sten Målspecifik behandling av urogenitala tumörsjukdomar Niméus, Emma Proteogenomic signatures for improved prognosis in recurring breast cancer Humblas fond Qian, Hong Unravelling the contribution of bone marrow niche to the development and treatment response of myeloid leukemia Rassidakis, Georgios Novel, genome based, biomarkers in T cell lymphomas in the era of personalized medicine: a project from the swedish T cell lymphoma working group

7 Rosenquist, Richard Dissecting the complex molecular landscape in chronic lymphocytic leukemia Sander, Birgitta Mapping and targeting dysregulated signalling pathways for individualized lymphoma therapy. Sangfelt, Olle Targeting DNA repair pathways controlled by ubiquitin ligase activities Siegbahn, Albert The development of methods for use in proton beam based radiotherapy and grid therapy Soussi, Thierry The UMD TP53 database: a critical resource to improve the clinical diagnosis of TP53 alteration in human cancer Staaf, Johan Genomic markers of DNA repair deficiency in triple negative breast cancer Humblas fond

8 Stenke, Leif Modulering av leukotrienrelaterad cellsignalering vid kronisk myeloisk leukemi ny individualiserad terapi med kurativ intention Strell, Carina Identification of a response predictive biomarker combination to identify malignant melanoma patients with benefit from checkpoint inhibiting therapy Ullén, Anders Translationella studier av metastaserad urinblåsecancer från identifiering av nya målmolekyler och behandlingsstrategier till kliniska prövningar Wiman, Klas Further studies of the mutant p53 targeting compound APR 246 with the aim of improved cancer therapy Xu, Dawei Omfattande analys av telomerasets påverkan av typiska kännetecken i urologiska maligniteter: Implikationer i precisionsonkologi Zetterberg, Anders High precision single cell genomics in personalised cancer medicine (PCM). Early prediction of micro metastatic disease in treatment decision

9 Ährlund Richter, Lars Pre clinical drug response evaluation following chemo or targeted therapy Österborg, Anders Forskningskoordinator till Enheten för Onkologisk Bioterapi